DNA Competitors & Alternatives
Compare Ginkgo Bioworks Holdings with similar stocks in the same industry
Biotechnology
DNA
Main Stock$7.37
Tradestie Score
53
Market Cap
$868.46M
Revenue Growth
-0.5%
Analyst Upside
+15.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.50
|
$552.46M | - | 45 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.21
|
$540.97M | - | 55 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.59
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.43
|
$529.35M | 5.8 | 57 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.14
|
$512.39M | - | 62 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$28.61
|
$505.12M | 1.7 | 58 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$105.80
|
$492.21M | - | 55 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.64
|
$474.20M | 26.8 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.95
|
$468.01M | - | 57 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.01
|
$463.20M | - | 54 | Compare |
More DNA Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry